Link to Home Page - Shire Logo
  • Go to other Shire websites

    Other Shire websites

    Shire Worldwide

    • Europe
    • Denmark
    • France
    • Germany
    • Rep. of Ireland
    • Italy
    • Netherlands
    • Spain
    • UK
    • Switzerland
    • Americas
    • Argentina
    • Brazil
    • Canada
    • Asia-Pacific
    • Australia

To be as brave as the people we help.

  • Home
  • About us
  • Products
  • Research and development
  • Careers
  • Investors
  • Media
  • Business development
  • Responsibility

Media

We aim to always provide clear communication to all our stakeholders.

  • Shire news RSS feed
  • Sign up for Email or SMS alerts
  • Our news
    • In the news
    • Partner news
  • Email and SMS alerts
  • What is Brave?
  • Media contacts
  • Print page
  • Email this page
  • Bookmark
  • Add to print basket
  • View print basket
Home > Media > Our news

Shire news

  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
01 Feb 2012 Total Voting Rights
01 Feb 2012 Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases
31 Jan 2012 Full Year 2011 results date notification – February 9, 2012
23 Jan 2012 Notification of major interests in shares (27KB PDF)
10 Jan 2012 Shire Acquires US Rights to Resolor® (prucalopride)
05 Jan 2012 Shire’s VENVANSE® (lisdexamfetamine dimesylate) Marketing Application accepted for review in Europe
03 Jan 2012 Total Voting Rights

Did you know...

You can sign up to receive email and SMS alerts so that you can keep up to speed with our latest news.

Email and SMS alerts

Did you know...

We donated over $35,000 in
outdated laboratory
equipment
to local
schools?


Our locations and global reach North America Asia Australia Europe South America Europe

Links

  • Sitemap
  • Contact Us
  • News Feed  

Legal

  • Disclaimer
  • Legal Notice
  • Privacy Policy and Cookies
© Shire 2012
Delivered by global3digital
Designed by Bostock and Pollitt